Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With Chronic Kidney Diseases Not on Dialysis

计划入组 60 人 · 首次发布于 2015 年 3 月 31 日

Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With ERSD Receiving Maintenance Hemodialysis

计划入组 60 人 · 首次发布于 2015 年 2 月 19 日

CAPRISA 012B

计划入组 76 人

HCW11-018

HCW11-027

HCW11-002

HCW Biologics Advances Novel T-Cell Engager HCW11-018b for Solid Tumors with Unique Cis-Binding Mechanism

HCW Biologics Signs Exclusive Distribution Deal with Akron Biotech for CAR-T Manufacturing Reagent HCW11-006

HCW Biologics and WY Biotech Launch Joint Venture Trimmune to Advance Cancer Immunotherapy HCW11-006